Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet

Midway through trading Friday, the Dow traded up 0.31% to 36,031.95 while the NASDAQ rose 0.54% to 15,788.64. The S&P also rose, gaining 0.43% to 4,669.15.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 47,693,510 cases with around 780,770 deaths. India confirmed a total of at least 34,414,180 cases and 462,690 deaths, while Brazil reported over 21,926,520 COVID-19 cases with 610,320 deaths. In total, there were at least 252,785,840 cases of COVID-19 worldwide with more than 5,098,390 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Communication services shares gained by 1% on Friday. Meanwhile, top gainers in the sector included PLAYSTUDIOS, Inc. MYPS, up 18% and MediaAlpha, Inc. MAX up 9%.


In trading on Friday, energy shares fell 0.4%.


Top Headline


AstraZeneca PLC AZN said its COVID-19 vaccine made a small contribution to earnings in Q3. It expects the shot to move to "modest profitability" on new orders.

AstraZeneca reported quarterly core earnings of $1.08 per share, beating analysts’ estimates of $0.62 per share. Total revenue jumped 50% year-over-year to $9.87 billion, in line with the consensus. In Q3, the Company posted $1.05 billion in COVID-19 vaccine sales.

AstraZeneca reaffirmed its FY21 adjusted EPS guidance at $5.05 - $5.40.

 

Equities Trading UP


Everspin Technologies, Inc. MRAM shares shot up 43% to $9.40 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.


Shares of Kura Sushi USA, Inc. KRUS got a boost, shooting 24% to $67.61 following narrower-than-expected quarterly loss.


Brilliant Earth Group, Inc. BRLT shares were also up, gaining 26% to $17.83 after reporting better-than-expected Q3 results.

Check out these big movers of the day


Equities Trading DOWN

Team, Inc. TISI shares tumbled 43% to $1.5350 after the company reported worse-than-expected Q3 EPS and sales results.


Shares of Acutus Medical, Inc. AFIB were down 43% to $3.7750. Acutus Medical reported third-quarter revenues of $4.6 million, up from $3.2 million a year ago. The non-GAAP loss per share narrowed from 90 cents to 87 cents. The results trailed expectations. Citing COVID-19 related uncertainty, the company lowered its full-year revenues guidance to $17 million to $17.5 million, below the $22.46 million consensus estimates.


Oncorus, Inc. ONCR was down, falling 43% to $6.28. Oncorus reported initial safety, tolerability, immune activation and positive clinical response data from its ongoing Phase 1 clinical study of ONCR-177, its lead viral immunotherapy candidate, at the SITC 2021.


Commodities

In commodity news, oil traded down 0.8% to $80.96, while gold traded down 0.1% to $1,863.50.


Silver traded down 0.1% Friday to $25.29 while copper rose 0.6% to $4.4235.


Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.17%, the Spanish Ibex Index fell 0.29% and the German DAX 30 gained 0.04%. Meanwhile, the London’s FTSE 100 fell 0.58%, French CAC 40 rose 0.32% and Italy’s FTSE MIB rose 0.17%.

Spain's annual inflation accelerated for a fourth consecutive month to 5.4% in October, while wholesale prices in Germany surged 15.2% year-over-year in October.


Economics


The University of Michigan's consumer sentiment index dropped to 66.8 in November from 71.7 in October.


The number of job openings fell by 191,000 from a month ago to 10.4 million in September.


The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...